Replimune Group, Inc – a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies – ...

Savara faces an FDA setback for Molbreevi, its aPAP treatment. Learn how the company plans to recover and file a new BLA by ...

The FDA has accepted for Priority Review the BLA for tividenofusp alfa for the treatment of Hunter syndrome, also known as MPS II.

Replimune Group, Inc. faces FDA setbacks with RP1, raising financial risks and dilution concerns. Click here to find out why ...

Quetta: Pakistan Army Military Intelligence officer, Major Anwar Kakar, was reportedly killed in a powerful blast in Quetta.

Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

Replimune (REPL) announced that the U.S. Food and Drug Administration, FDA, has issued a Complete Response Letter, CRL, regarding the Biologics ...

Vusolimogene oderparepvec is a genetically modified herpes simplex type 1 virus designed to directly destroy tumors and generate an anti-tumor immune response.

The Baloch Liberation Army has claimed responsibility for a bomb blast in Quetta that killed Major Anwar Kakar, a senior ...

ISLAMABAD: Pakistan on Friday called on the international community to classify the Majeed Brigade as an alias of the banned ...

The Baloch Liberation Army (BLA) has claimed responsibility for a series of coordinated attacks on Pakistani security forces ...

Security forces killed four BLA terrorists in an intelligence-based operation in Kalat, Balochistan, according to ISPR. The hideout was destroyed and a large cache of weapons recovered. The operation ...